Bio Feature
Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
In an exclusive interview with BioPharma APAC, Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZ...
November 15, 2024 | Interview
Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...
November 01, 2024 | Interview
Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
As JLABS Singapore marks its first anniversary, Alessandro Falcone, Head of JLABS Singapore, speaks with BioPharma APAC about the incubator’s rapid s...
October 30, 2024 | News
Why Singapore is the World’s New Pharma Powerhouse: Unpacking the Secrets Behind Its Manufacturing Boom
Singapore’s pharmaceutical revolution: How data and digital transformation are fueling a global hub Once primarily recognized for it...
October 22, 2024 | Opinion | By Venkatesh Arunachalam, General Manager of the Life Science Manufacturing group at Cognizant
Sanyou Bio CEO Lang Guojun Introduces World’s Largest Super-Trillion Molecule Library
In an interview with Tongxieyi, Sanyou Bio’s CEO Lang Guojun proudly announced the launch of the world’s largest super-trillion molecule librar...
October 21, 2024 | Interview
Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...
October 17, 2024 | Interview
Overcoming Commercial Hurdles in Biopharma: A Conversation with Sudhir Kandarth, General Manager, Asia Pacific, Veeva Systems
As biopharma companies navigate an increasingly complex commercial landscape, achieving excellence demands more than innovation alone. With shifts ...
October 11, 2024 | Interview
BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
As China continues to solidify its position as a global biotech hub, BIOCHINA 2025 promises to be a pivotal event for connecting exhibitors with top-tier C...
September 27, 2024 | Interview
Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
Thermo Fisher Scientific continues its global expansion with the opening of a new bioanalytical laboratory in GoCo Health Innovation City, Sweden. In this ...
September 27, 2024 | Expert Insight
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
This is especially concerning in Asia, where rates of illness are expected to rise in the coming years. When it comes to breast cancer, for instance, Asia ...
September 20, 2024 | Opinion | By Deepti Saraf General Manager, Roche (Malaysia) Sdn. Bhd.
Redefining Patient Safety in the Age of Healthtech
A few weeks ago, I sat down to watch Live to 100: Secrets of the Blue Zones on Netflix. The documentary explores pockets of the world where people ...
September 18, 2024 | Opinion | By Reuben Ong, Vice President of Healthcare, DKSH
Jorge Sahlieh on Adapting Cardinal Health’s Products and Services to Tackle Healthcare's Pressing Financial and Workforce Challenges
In this exclusive interview with BioPharma APAC, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, sh...
September 12, 2024 | Interview
Inside Asia-Pacific’s Cell and Gene Therapy Evolution: A Conversation with Raymond Chow, VP of Commercial, APAC at Cytiva
In an interaction with BioPharma APAC, Raymond Chow, Vice President of Commercial for Asia-Pacific at Cytiva, shares his insights on the rapidly evolving l...
September 02, 2024 | Interaction
New Trials, New Pills—The Pharma Rollercoaster Continues!
The Landscape of Innovation: A Double-Edged Sword The pace at which pharmaceutical companies are developing new drugs is nothing short of astonish...
August 30, 2024 | Report
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
